Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    "methodist hospital" | Open Studies | "Cardiomyopathies" | United States, Texas | Houston
Show Display Options
Rank Status Study
1 Recruiting Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Condition: Hypertrophic Cardiomyopathy
Interventions: Drug: Eleclazine;   Drug: Placebo
2 Recruiting MOMENTUM 3 Continued Access Protocol
Condition: Advanced Refractory Left Ventricular Heart Failure
Intervention: Device: HeartMate 3 LVAS

Indicates status has not been verified in more than two years